福森药业公布2024年业绩 股权持有人应占亏损约为1.89亿元 同比增长约4.2倍

智通财经网
31 Mar

智通财经APP讯,福森药业(01652)公布2024年业绩,收益约为3.26亿元,同比减少约42.4%。毛利约1.626亿元,同比减少约45.7%。公司股权持有人应占亏损约为1.89亿元,同比增长约4.2倍。每股基本亏损约为26分。公告称,收益减少主要由于销量减少。该行业整体进入渠道去库存阶段。该集团终端渠道的库存结构调整已导致集团销量于短期下滑。

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10